Department of Biostatistics, NYU School of Global Public Health, New York, NY, USA.
Department of Communication, University of Utah, Salt Lake City, UT, USA.
Cancer Causes Control. 2024 Aug;35(8):1201-1212. doi: 10.1007/s10552-024-01878-0. Epub 2024 May 3.
Genetic testing for gene mutations which elevate risk for breast cancer is particularly important for women diagnosed at a young age. Differences remain in access and utilization to testing across social groups, and research on the predictors of interest in genetic testing for women diagnosed at a young age is limited.
We examined the relationships between subjective social status (SSS) and variables previously identified as possible predictors of genetic testing, including genome sequencing knowledge, genetic worry, cancer worry, health consciousness, decision-making preferences, genetic self-efficacy, genetic-related beliefs, and subjective numeracy, among a cohort of women who were diagnosed with breast cancer at a young age.
In this sample (n = 1,076), those who had higher SSS had significantly higher knowledge about the limitations of genome sequencing (Odds Ratio (OR) = 1.11; 95% CI = 1.01-1.21) and significantly higher informational norms (OR = 1.93; 95% CI = 1.19-3.14) than those with lower SSS. Similarly, education (OR = 2.75; 95% CI = 1.79-4.22), health status (OR = 2.18; 95% CI = 1.44-3.31) were significant predictors among higher SSS women compared to lower SSS women in our multivariate analysis. Lower SSS women with low self-reported income (OR = 0.13; 95% CI = 0.08-0.20) had lower odds of genetic testing interest. Our results are consistent with some prior research utilizing proxy indicators for socioeconomic status, but our research adds the importance of using a multidimensional indicator such as SSS to examine cancer and genetic testing predictor outcomes.
To develop interventions to improve genetic knowledge, researchers should consider the social status and contexts of women diagnosed with breast cancer at a young age (or before 40 years old) to ensure equity in the distribution of genetic testing benefits.
对于年轻时被诊断出患有乳腺癌的女性来说,针对乳腺癌风险基因的基因突变进行基因检测尤为重要。不同社会群体在获得和使用基因检测方面仍存在差异,而针对年轻时被诊断出患有乳腺癌的女性对基因检测的兴趣的预测因素的研究则很有限。
我们考察了主观社会地位(SSS)与先前被确定为基因检测可能预测因素的变量之间的关系,这些变量包括全基因组测序知识、遗传担忧、癌症担忧、健康意识、决策偏好、遗传自我效能、遗传相关信念和主观算数能力,研究对象为一群年轻时被诊断出患有乳腺癌的女性。
在本研究样本(n=1076)中,SSS 较高的患者对全基因组测序的局限性有更深入的了解(优势比(OR)=1.11;95%置信区间(CI)=1.01-1.21),对信息规范的认识也更高(OR=1.93;95%CI=1.19-3.14),而 SSS 较低的患者则较低。同样,在多变量分析中,与 SSS 较低的患者相比,SSS 较高的患者中,教育(OR=2.75;95%CI=1.79-4.22)和健康状况(OR=2.18;95%CI=1.44-3.31)是显著的预测因素。而在 SSS 较低的患者中,自我报告收入较低(OR=0.13;95%CI=0.08-0.20)的患者对基因检测的兴趣较低。我们的研究结果与利用社会经济地位的替代指标进行的一些先前研究一致,但我们的研究增加了使用多维指标(如 SSS)来检验癌症和基因检测预测结果的重要性。
为了制定改善基因知识的干预措施,研究人员应考虑年轻时(或 40 岁之前)被诊断出患有乳腺癌的女性的社会地位和背景,以确保基因检测效益在不同社会群体中的公平分配。